跳至主要内容
临床试验/JPRN-UMIN000011437
JPRN-UMIN000011437招募中未知

Deferred combined androgen blockade therapy using antiandrogen in hormone-refractory metastatic prostate cancer patients treated with Degarelix, GnRH antagonist - Deferred combined androgen blockade therapy using antiandrogen in hormone-refractory metastatic prostate cancer patients treated with Degarelix, GnRH antagonist

Osaka University Graduate School of Medicine, Department of Organ Specific Regulation (Urology)0 个研究点目标入组 200 人开始时间: 2013年8月9日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
Male

入选标准

  • 未提供

排除标准

  • Previous or present endocrine treatment for prostate cancer.

研究者

发起方
Osaka University Graduate School of Medicine, Department of Organ Specific Regulation (Urology)

相似试验

Deferred combined androgen blockade therapy using... | 临床试验